Literature DB >> 8347484

Detection of an oestrogen receptor-like protein in human meningiomas by band shift assay using a synthetic oestrogen responsive element (ERE).

S G Koehorst1, H M Jacobs, J H Thijssen, M A Blankenstein.   

Abstract

When a ligand binding or enzyme immunoassay is used, meningiomas are found to be rich in progestin receptors (PR) whereas oestrogen receptors (ER) are virtually undetectable. A protein that can bind to an oestrogen responsive element (ERE) was detected in meningiomas, by using the band-shift assay. The binding of ER to the ERE is inhibited by the anti-ER monoclonal antibody ER-P31, which is directed to the A/B domain of the ER, indicating that the binding protein is an ER-like protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347484      PMCID: PMC1968567          DOI: 10.1038/bjc.1993.330

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Immunohistochemical assessment of ER-P31, a mouse anti-oestrogen receptor protein monoclonal antibody in human breast cancers: comparison with ER-ICA (Abbott) and radioligand assays.

Authors:  S Y Wong; A Purdie; H F Sewell; L Wilkinson; B Angus; B Westley; C H Horne
Journal:  Tumour Biol       Date:  1991

2.  Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.

Authors:  S G Koehorst; H M Jacobs; J H Thijssen; M A Blankenstein
Journal:  J Steroid Biochem Mol Biol       Date:  1993-04       Impact factor: 4.292

3.  Aberrant oestrogen receptor species in human meningioma tissue.

Authors:  S G Koehorst; H M Jacobs; M G Tilanus; A G Bouwens; J H Thijssen; M A Blankenstein
Journal:  J Steroid Biochem Mol Biol       Date:  1992-09       Impact factor: 4.292

Review 4.  Estrogen receptor variants in clinical breast cancer.

Authors:  W L McGuire; G C Chamness; S A Fuqua
Journal:  Mol Endocrinol       Date:  1991-11

5.  Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols.

Authors:  M A Blankenstein; G Blaauw; S W Lamberts; E Mulder
Journal:  Eur J Cancer Clin Oncol       Date:  1983-03

6.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

7.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Truncated forms of DNA-binding estrogen receptors in human breast cancer.

Authors:  G K Scott; P Kushner; J L Vigne; C C Benz
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas.

Authors:  R L Martuza; D C Miller; D T MacLaughlin
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

10.  Sex steroid receptors in human meningiomas.

Authors:  G Blaauw; M A Blankenstein; S W Lamberts
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more
  2 in total

1.  Neurosurgery and biology of meningiomas. Proceedings of a symposium. Salzburg, February 4-6, 1994.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Authors:  S Trivedi; M Piccart; C Muquardt; N Gilot; S Hadiy; D Patel; G Leclercq
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.